(INCY:Consolidated Issue Listed on NASDAQ Global Select )
Earnings & Estimates Summary - INCYTE CORP (INCY)
2013 revenues at Incyte Corporation totaled $354.9M USD, while annual losses equaled $0.44 per share.
Quarterly Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Quarterly Earnings
Incyte Corporation reported 2nd quarter 2014 on 08/2/2014.
Annual Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Annual Earnings
Incyte Corporation reported annual 2013 losses of $0.44 per share on 02/14/2014.
Quarterly Revenues - INCYTE CORP (INCY)
Annual Revenues - INCYTE CORP (INCY)
Incyte Corporation's Annual Revenues
Incyte Corporation had revenues for the full year 2013 of $354.9M USD. This was 19.5% above the prior year's results.
|ARIAD Pharmaceuticals Inc||$7.11 USD||-0.18|
|Array BioPharma Inc||$4.03 USD||+0.08|
|Evotec AG||€3.23 EUR||-0.023|
|GlaxoSmithKline SAE||£12.94 EGP||0.00|
|Infinity Pharmaceuticals Inc||$15.01 USD||-0.23|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|